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Injury and loss of podocytes are leading factors of glomerular disease and renal failure. The postmitotic podocyte is the primary glomerular target for toxic, immune, metabolic, and oxidant stress, but little is known about
how this cell type copes with stress. Recently, autophagy has been identified as a major pathway that delivers
damaged proteins and organelles to lysosomes in order to maintain cellular homeostasis. Here we report that
podocytes exhibit an unusually high level of constitutive autophagy. Podocyte-specific deletion of autophagyrelated 5 (Atg5) led to a glomerulopathy in aging mice that was accompanied by an accumulation of oxidized
and ubiquitinated proteins, ER stress, and proteinuria. These changes resulted ultimately in podocyte loss
and late-onset glomerulosclerosis. Analysis of pathophysiological conditions indicated that autophagy was
substantially increased in glomeruli from mice with induced proteinuria and in glomeruli from patients with
acquired proteinuric diseases. Further, mice lacking Atg5 in podocytes exhibited strongly increased susceptibility to models of glomerular disease. These findings highlight the importance of induced autophagy as a key
homeostatic mechanism to maintain podocyte integrity. We postulate that constitutive and induced autophagy
is a major protective mechanism against podocyte aging and glomerular injury, representing a putative target
to ameliorate human glomerular disease and aging-related loss of renal function.
*OUSPEVDUJPO
The kidney filtration barrier is a unique structure characterized by
a complex 3-dimensional framework of podocytes and endothelial
cells. Podocytes form fine interdigitating foot processes, which
envelope the glomerular capillaries (1, 2). In order to maintain the
kidney filtration barrier, podocytes have to function as specific
pericytes, counteracting the high transmural distending forces;
serve as molecular sieves that establish the selective permeability
properties of the glomerular filter; secrete soluble factors to regulate other cell types within the glomerulus; and coordinate dynamic signaling events at the slit diaphragm. The combination of all
these functions in one cell is reflected by the high differentiation,
the neuron-like appearance, and the very complex cytoarchitecture
of podocytes. Unlike all other cell types forming the kidney filtration apparatus, podocytes have a very limited capacity for cell division and replacement (2). The fate of podocytes therefore entirely
depends on their ability to cope with stress.
Recent research indicates that a decrease in the number of
glomerular podocytes is a predictor for the progression of renal
diseases, including focal segmental glomerulosclerosis and diaAuthorship note: Björn Hartleben and Markus Gödel contributed equally to this
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betic nephropathy (3–5). In addition, increased appearance of
podocytes and podocyte constituents in the urine is associated
with glomerulosclerosis (6, 7). Together these data underline the
concept that loss of podocytes triggers glomerulosclerosis. Furthermore, progressive glomerulosclerosis leads to an irreversible
loss of renal function, ultimately culminating in end-stage renal
disease (ESRD). Podocyte injury is therefore a key determinant
of glomerular diseases and ESRD. Glomerulosclerosis in combination with loss of glomerular filtration also typically occurs in
the aging human kidney. Animal models indicate that the agedependent development of glomerulosclerosis is due to a loss of
podocytes (8, 9). However, the mechanism by which this might
occur has not been elucidated.
Increasing age causes a progressive deterioration of most tissues, leading to an impairment of cell function and increased
vulnerability to environmental challenges. The accumulation of
damaged proteins, lipids, and organelles usually accounts for the
age-associated malfunctioning of individual cells (10). Recent
studies have demonstrated that a decreased rate of protein degradation is responsible for the age-dependent functional decline in
many cell types (10).
The 2 major protein degradation pathways in eukaryotes are
the ubiquitin-proteasome system (UPS) and autophagy (11).
Both of these systems are responsible for the efficient degradation and turnover of proteins within the cell. Failure of either
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the UPS or autophagy has been associated with disease, while the
upregulation of these processes has been shown to ameliorate
certain disease entities (11, 12). The proteasome is responsible for
the selective degradation or recycling of short-lived cytosolic proteins but also regulates the turnover of some long-lived proteins.
Due to the size of the narrow barrel of the proteasome and the
specificity of the process, many proteins and organelles cannot
be degraded by the UPS. Autophagy is responsible for the bulk
degradation of long-lived cytosolic proteins and organelles. Unlike
proteasomal degradation, autophagic degradation is thought to
be largely nonspecific. Portions of the cytoplasm are sequestered
within cytosolic double-membrane vesicles, the autophagosomes,
and damaged proteins and organelles are delivered to the lysosome (11). Autophagy is a major homeostatic and quality control
mechanism to maintain cellular integrity (11). Thus, constitutive
autophagy has been shown to function as a cell-repair mechanism
that is particularly important for long-lived postmitotic cells such
as neurons (11). Similar to neurons, podocytes are terminally differentiated cells, and autophagosomes have been shown to be present in podocytes in vitro (13), in mice (14), and in human renal
biopsies (15). However, the functional significance of autophagy
for glomerular development, maintenance, and disease progression has remained unknown.
Here we demonstrate the critical role of autophagy for glomerular maintenance in aging glomeruli. Moreover, these data provide
the first evidence that glomerular injury — a major risk factor for
ESRD (5) — triggers autophagy to prevent the progression of glomerular disease. The dynamic regulation of protein degradative
pathways in the podocyte appears to be a general theme for glomerular aging and glomerular disease progression.
The Journal of Clinical Investigation

3FTVMUT
Glomerular podocytes exert high levels of autophagy under basal conditions. We hypothesized that the postmitotic podocyte depends on
autophagy to maintain cellular homeostasis, and we used transgenic mice expressing the fluorescent microtubule-associated protein 1 light chain 3, GFP-LC3, an autophagosome marker, to monitor autophagy in vivo (14). Strikingly, only glomerular podocytes
displayed clearly detectable levels of autophagosomes within the
kidney under basal conditions (Figure 1, A and B). Moreover, podocytes exerted unusually high levels of autophagosomes compared
with other kidney cells (Figure 1C). However, increased numbers
of autophagic vacuoles do not necessarily correlate with increased
autophagic activity or flux, as such an increase can also result from
impaired autophagosome/lysosome fusion or constitutively low
lysosomal activity. To study the actual rate of autophagosome formation in podocytes, we generated a podocyte cell line expressing
GFP-LC3. Blockade of autophagosomal degradation with the lysosomal inhibitor chloroquine induced a rapid accumulation of GFPLC3–positive autophagosomes in GFP-LC3–expressing differentiated podocytes (Figure 1D). Autophagic flux rates of differentiated
podocytes and inner medullary collecting duct (IMCD) cells were
compared. Densitometric analysis of Western blots from cells incubated with chloroquine showed a significantly faster accumulation
of converted LC3-II in podocytes, indicating a high rate of autophagic flux under non-starving conditions (Figure 1, E and F).
Autophagy-related 5-dependent autophagy is dispensable for glomerular
development. To analyze the autophagic activity during podocyte
differentiation, kidney sections of newborn transgenic GFP-LC3
mice were stained with the podocyte nucleus marker WT1 and
the foot process marker podocin. Since glomerular development
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occurs asynchronously, all glomerular developmental stages were
monitored on day 1 kidney sections. GFP-LC3–positive autophagosomes were not detected before late podocyte differentiation in
the late capillary loop stage (Figure 2A). To further elucidate the
role of autophagy in podocyte development, we analyzed constitutive autophagy-related 5 (Atg5) knockout mice (16). Glomeruli and
podocytes in kidneys from Atg5-deficient E19 embryos (Atg5–/–)
showed no morphological abnormalities in histology and electron
microscopy despite loss of LC3 conversion, indicating that the
autophagic activity of podocytes is not required for their normal
differentiation (Figure 2, B–D). We next generated podocyte-specific Atg5 knockout mice (Atg5Δpodocyte) by crossing Atg5-floxed mice
(Atg5flox/flox) with podocin-Cre mice (17). In podocin-Cre–positive
mice, floxed alleles are selectively excised in glomerular podocytes
during late glomerular development (18). Western blot analysis
from isolated glomeruli confirmed the almost complete loss of
glomerular Atg5 and accumulation of LC3-I (Figure 2E), thus
confirming that the high levels of autophagy observed in the
glomerulus can be attributed to podocytes. To confirm the ablation of autophagy in podocytes, the Atg5Δpodocyte mice were subsequently crossed to GFP-LC3 transgenic mice. In these triple transgenic mice, glomerular GFP-LC3–positive vesicles were completely
absent and GFP-LC3 was distributed diffusely in the cytoplasm
(Figure 2F and Supplemental Figure 1; supplemental material
available online with this article; doi:10.1172/JCI39492DS1). Like
in the constitutive Atg5 knockout animals, the kidneys of newborn
Atg5Δpodocyte mice displayed no obvious histological abnormalities
(data not shown). Glomerulus counts of kidneys from Atg5Δpodocyte
mice and control littermates were almost identical, indicating that
podocyte-specific Atg5 deletion did not affect the number of developing nephrons (Figure 2G). However, these results do not exclude
the possibility that Atg5-independent autophagy might compensate for correct development in Atg5-deficient animals (19).
Functional cross-talk between the ubiquitin proteasome pathway and
autophagy in podocytes. To determine the physiological role of
autophagy in podocytes, we analyzed Atg5Δpodocyte and control mice
in age-matched groups. Up to 2–4 months after birth, Atg5Δpodocyte
mice were indistinguishable from control littermates as analyzed
by kidney histology, albuminuria, and glomerular ultrastructure
(Figure 3, A–C). In an 8- to 12-month follow-up, Atg5Δpodocyte mice
developed albuminuria that was mild but significantly higher
than in control mice (Figure 3A). Interestingly, acute induction
of podocyte-specific Atg5 knockout in 12-week-old doxycyclineinducible Atg5flox/flox;Podocin-rtTA+;tetO-Cre+ mice caused a rapid
onset of albuminuria, suggesting that the constitutive loss of
Atg5 might be partially compensated by other pathways such as
chaperone-mediated autophagy (20), Atg5-independent autophagy (19), or an upregulated proteasome activity (21) (Supplemental Figure 2). No obvious histological phenotype was detectable
in 12-month-old podocyte-specific Atg5 knockout mice (Figure
3B). However, electron microscopy analysis identified significant
changes, including vacuolar degeneration and large cystic structures (Figure 3D) in 12-month-old mice. Similar changes could
already be seen in 8-month-old mice (data not shown). Further
magnification revealed additional ultrastructural abnormalities
such as cisternal distension of rough ER and aberrant membranous structures similar to those observed in Atg7-deficient livers
(22), suggesting an abnormal turnover of organelles (Supplemental Figure 3). Surprisingly, and in contrast to many other tissues
(17, 21–25), the genetic ablation of autophagy did not cause a
The Journal of Clinical Investigation

significant accumulation of poly-ubiquitinated proteins in the
glomeruli of 8-month-old mice (Figure 3E). Although podocytes
account for less than 20% of all glomerular cells, podocyte-specific
deletion of autophagy resulted in a remarkable increase of total
glomerular proteasome activity in these mice, as measured by chymotrypsin-like activity (Figure 3F), suggesting that the enhanced
proteasome activity antagonizes an accumulation of poly-ubiquitinated proteins. To test the concept of a compensatory action of
the proteasome in Atg5Δpodocyte animals in vivo, Atg5Δpodocyte and control mice were injected with the proteasome inhibitor bortezomib.
Bortezomib injection resulted in a significant decrease of proteasome activity in total kidney lysates (Figure 3G) and caused a significant albuminuria in 6-month-old Atg5Δpodocyte mice compared
with control littermates 24 hours after injection (Figure 3H). A
functional coupling of autophagy and the UPS was also suggested
by the fact that inhibition of the UPS by MG132 resulted in an
increased autophagic activity, as documented by the conversion of
cytoplasmic LC3-I into the membrane-bound LC3-II (Figure 3I)
and the formation of GFP-LC3–positive autophagosomes in GFPLC3–expressing differentiated podocytes (Figure 3J).
Atg5 deficiency results in age-dependent late-onset glomerulosclerosis. In
a 20- to 24-month follow-up, Atg5Δpodocyte mice developed a progressive decline in glomerular function as evidenced by proteinuria
(Figure 4A). Upon histology, 20- to 24-month-old Atg5Δpodocyte mice
displayed significantly increased segmental or complete glomerular sclerosis compared with control littermates (Figure 4, B and C).
In agreement with the measured proteinuria, proteinaceous casts
and tubular dilatation were seen (Figure 4B). The expression and
targeting of slit diaphragm proteins in non-sclerosed glomeruli
displayed by immunofluorescence and specific immunogold stainings for nephrin and podocin seemed not to be severely affected,
indicating that the glomerulopathy was not primarily caused by a
defective slit diaphragm function (Supplemental Figure 4). Electron microscopy analysis revealed extensive vacuolar degeneration
of podocyte cell bodies and foot process fusion (Figure 4D). Many
of the vacuoles consisted of expanded ER lumens (Figure 4D).
Furthermore, Atg5Δpodocyte podocytes displayed typical features of
aging cells, such as signs of mitochondrial damage (Figure 4E),
and accumulation of intra-lysosomal indigestible material, such
as lipofuscin (Figure 4, F and G).
ER stress and the accumulation of oxidized and ubiquitinated protein
aggregates result in a loss of podocytes in Atg5Δpodocyte mice. The dilated ER
lumens stained positive for Calnexin by immunofluorescence (Figure 5A), indicating ER stress, which was confirmed by the detection of upregulated ER stress markers from isolated glomeruli of
Atg5Δpodocyte mice (Figure 5B). Interestingly, the proteasomal activity
of glomeruli from these Atg5Δpodocyte mice was significantly reduced
compared with glomeruli from control mice (Figure 5C). In agreement with the reduced proteasomal activity, Western blot analysis
(here shown as a short exposure) demonstrated a significant accumulation of poly-ubiquitinated proteins in glomeruli of Atg5Δpodocyte
mice (Figure 5D). Accumulation of ubiquitin and the lysosomal
marker Lamp2 was also confirmed by confocal microscopy (Supplemental Figure 5, A and B). In addition, a dramatic accumulation of p62/SQSTM1, a ubiquitin-binding scaffold protein that
colocalizes with ubiquitinated protein aggregates in many neurodegenerative diseases (26), was detected, and p62 seemed to be
deposited in larger aggregates as shown by immunofluorescence
(Figure 5, E and F). These data suggest that the incremental accumulation of toxic proteins and altered organelles in autophagy-
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deficient podocytes might ultimately overwhelm the proteasome-dependent compensatory protein degradation, resulting in
podocyte injury and glomerulosclerosis. Since the deposits of damaged proteins and altered organelles are particularly detrimental
in non-dividing cells, autophagy-deficient podocytes share strik
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ing characteristics with aging neurons (17, 23, 27). Accumulation
of oxidized proteins is widely considered a hallmark of aging in
many tissues (28). To quantitatively assess the accelerated process
of cellular aging, we measured the content of oxidized proteins in
Atg5Δpodocyte mice. Indeed, glomeruli from 22-month-old Atg5Δpodocyte
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mice significantly accumulated oxidized proteins compared with
glomeruli from control animals (Figure 5G). In terminally differentiated neurons, several ubiquitin-associated proteins such as the
ubiquitin carboxyterminal hydrolase L1 (UCH-L1) are known to
be involved in the pathogenesis of neurodegenerative diseases and
neuronal aging (11, 29). UCH-L1, recently identified in podocytes
(30), was dramatically upregulated in glomeruli from autophagydeficient mice (Figure 5H). To asses whether the podocyte damage
The Journal of Clinical Investigation

was accompanied by a loss of podocytes, we compared the number
of glomerular podocytes from control and Atg5Δpodocyte mice at different ages. Indeed, a significantly reduced number of podocytes
was already detected in non-sclerosed glomeruli of 22-month-old
Atg5Δpodocyte mice, indicating that podocyte loss precedes the development of glomerulosclerosis (Figure 5I). These results clearly
demonstrate the importance of basal, constitutive autophagy in
maintaining glomerular function in aging mice.
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Upregulation of autophagy in proteinuric diseases. The late onset of proteinuria in Atg5Δpodocyte mice enabled us to study the role of autophagy during glomerular injury. First we explored whether proteinuria leads to changes of autophagosome formation in GFP-LC3;
Atg5WT/WT mice. Application of BSA overload induced an approximately 3-fold increase of GFP-LC3–positive autophagosomes
(Figure 6, A and B), indicating a role for autophagy in response to
proteinuria. To examine the role of autophagy in human kidney
disease, we examined ATG3 mRNA levels using quantitative realtime PCR (rt-PCR) in microdissected glomeruli from patients with
acquired proteinuric diseases (31). Intriguingly, ATG3 mRNA levels
were 4- and 10-fold higher in podocytes from patients with focal segmental glomerulosclerosis and membranous glomerulonephritis
compared with control samples (Figure 6C). Immunofluorescence
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staining of 2 patient biopsy samples for the autophagosome marker
LC3 showed an upregulation of autophagosomes in podocytes in
membranous glomerulonephritis compared with controls (pretransplant allograft biopsies) (Figure 6D).
Autophagy is critically involved in podocyte stress adaptation. Autophagy can have opposing effects on cell survival (32). To clarify the
role of induced autophagy in glomerular stress, we applied several
glomerular disease models on non-proteinuric young (4–6 months
old) Atg5Δpodocyte and control mice. Injection of puromycin aminonucleoside (PAN) (33, 34) or Adriamycin (35) resulted in a tremendous
increase of albuminuria in young, non-proteinuric Atg5Δpodocyte mice
compared with control littermates (Figure 7, A and E), with the
subsequent development of glomerulosclerosis (Figure 7, B and F),
foot process fusion (Figure 7, C and G), and loss of podocytes (Fig-
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ure 7, D and H), indicating that loss of autophagy dramatically
sensitized animals toward the development of glomerular diseases.
In addition, low doses of BSA (36, 37) or LPS (38) caused significantly higher transient albuminuria in Atg5Δpodocyte mice compared
with control littermates (Supplemental Figure 6).
These findings strongly support the hypothesis that autophagy
defends the integrity of podocytes against glomerular disease progression (illustrated in Supplemental Figure 7).
%JTDVTTJPO
Autophagy is a cellular pathway involved in protein and organelle
degradation with an amazing number of connections between cellular homeostasis and human disease (11). Our results here highlight
the critical role of autophagy as a determinant of glomerular aging
and glomerular disease (illustrated in Supplemental Figure 7).
The Journal of Clinical Investigation

Glomerular diseases are primarily responsible for the rising costs
associated with ESRD worldwide (5). Due to its complexity and
its postmitotic nature, the podocyte represents the most fragile
component of the glomerular filtration barrier. In most human
glomerulopathies, podocyte foot process effacement is a hallmark of glomerular injury leading to proteinuria (39). Failures of
reparative mechanisms promote persistent proteinuria and the
development of glomerulosclerosis (39). Unfortunately, very little
has been known on the molecular nature of the reparative mechanisms that defend the podocyte against environmental stress and
cellular aging. The understanding of this missing link could be
the basis for successful therapeutic prevention of irreversible glomerulosclerosis. Our data now reveal autophagy as an important
mechanism for podocyte homeostasis. Autophagy has previously
been shown to be an essential cell repair and turnover mecha-
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nism for postmitotic cells such as neurons (10, 11). Strikingly,
in the kidney, glomerular podocytes most prominently display
autophagic activity. Atg5-deficient podocytes that are incapable
of performing autophagy progressively accumulate biological
“garbage” such as damaged mitochondria and ubiquitinated protein aggregates, underlining that the removal of this cellular waste
depends on autophagy in podocytes. The compromised clearance
of old and/or damaged mitochondria by autophagy coupled with
reduced turnover of long-lived proteins probably contributes to
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the intracellular accumulation of oxidized proteins seen in Atg5deficient podocytes. Podocytes are particularly susceptible to oxidative injury (40). Both ER stress and oxidative stress ultimately
lead to irreversible podocyte injury and podocyte loss. This clearly
distinguishes podocytes from other glomerular structures that are
efficiently renewed due to proliferation, providing a dilution of
oxidatively or otherwise damaged proteins and cell organelles.
The efficiency of autophagy seems to be a direct determinant
of cellular aging for long-lived glomerular podocytes. Indeed,
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autophagy-deficient podocytes perfectly phenocopied many agerelated cellular alterations (Figures 4 and 5). Most prominent
signs of this accelerated aging in Atg5-deficient podocytes are
the accumulation of lipofuscin, the formation of ubiquitinated
protein aggregates and aggresomes, the occurrence of damaged
mitochondria, and the increase in the load of oxidized proteins.
To our knowledge this is the first genetic mouse model clearly featuring an aging podocyte. Aging in humans and rodents
progressively impairs renal function (5, 8, 41). The age-related
structural kidney changes are characterized by loss of podocytes
and glomerulosclerosis (5, 42). The exact mechanisms underlying age-dependent renal injury are unknown. Even in the
absence of known risk factors such as hypertension or diabetes,
otherwise healthy individuals (65 years old or older) frequently
present glomerulosclerosis (5). The autophagy-lysosome system
undergoes striking changes in aging cells. Aging in general leads
to a reduction in autophagosome formation and autophagosome-lysosome fusion (10, 43). It is intriguing to speculate that
a gradual decrease of glomerular autophagic activity with age
could play a major role in the functional decline of renal function in human aging kidneys.
In most cases, the ultimate fate of defective proteins identified
by quality control systems is degradation by either the autophagy-lysosome system or the UPS. Both of these degradation pathways have been implicated in the pathogenesis of neurodegenerative disease (11). However, the UPS and autophagy were long
viewed as independent degradation systems. Interestingly, in the
podocyte the UPS and the autophagy-lysosome system appeared
to be functionally coupled, as Atg5-deficient podocytes did exert
highly upregulated proteasome activities at young ages and the
occurrence of a more severe podocyte phenotype in old mice
seemed to be correlated with the decline in compensatory proteasome activity. In addition, inhibition of the UPS resulted in
an increased autophagic activity in wild-type podocytes. Similar induction of autophagy has been observed in response to
genetic impairment of the proteasome in Drosophila melanogaster (44). These results might suggest that podocytes can switch
between autophagy and the UPS, and that each system can at
least partially maintain the clearance of intracellular degradation products in podocytes. One simple possible mechanism of
such an autophagy-UPS interaction could be that the autophagic machinery directly degrades proteasomal components, which
would explain the increased proteasomal activity in Atg5-deficient podocytes. Although unproven at this point, it seems possible that the upregulation of alternative proteolytic pathways
in constitutively autophagy-deleted tissues contributes to the
observed phenotypes not only in podocytes, but also in other
tissues such as cardiomyocytes, where heart-specific constitutive and temporally controlled Atg5 deletion caused significantly
different phenotypes (21). Thus, in contrast to the traditional
notion of the UPS and autophagy providing discrete routes of
degradation for short-lived and long-lived proteins, our data
support recent findings indicating that a subset of proteins may
be degraded by either pathway (45, 46).
Recently, it has been shown that autophagy can occur through
an Atg5/Atg7-independent alternative pathway (19). This underlines the complexity of protein degradative pathways. Atg5-dependent macroautophagy has been demonstrated to be crucial for
basal and starvation-induced autophagy (11), for neuronal protein
aggregate clearance, and for stress adaptation (11, 21). In contrast,
The Journal of Clinical Investigation

the alternative Atg5-independent autophagy can be triggered by
cellular stress in vitro and functions in the autophagic elimination
of organelles during erythrocyte differentiation in vivo (19). In the
future it will be important to further dissect the interplay of Atg5dependent autophagy, Atg5-independent autophagy, chaperonemediated autophagy, and other proteolytic pathways.
Despite the important function of basal autophagy in podocytes, the requirement for autophagy is even more evident under
glomerular disease conditions. Our data show that the autophagic
machinery is induced in proteinuric animal models as well as in
human glomerular diseases. Since autophagy can have opposing
effects on cell survival (32), we proofed whether this process is a
causative or a compensatory mechanism by comparing models of
glomerular stress in wild-type and Atg5Δpodocyte mice. Intriguingly,
autophagy deficiency dramatically sensitized podocytes toward
glomerular stress. Thus, autophagy is a novel cellular stress surveillance factor for podocytes that appears to function both as
a sensor of stress stimuli and as an effector, which coordinates
podocyte homeostasis.
In summary, this study identifies basal autophagy as crucial
factor for glomerular maintenance and glomerular aging (Supplemental Figure 7). In addition, we demonstrate the importance of
induced autophagy in glomerular injury — a major risk factor for
glomerular disease and end-stage kidney disease (5). It is very reasonable to assume that autophagy could be a novel therapeutic
target (47) for the treatment of glomerular diseases. However, in
any attempt at manipulating podocyte autophagy therapeutically,
it will be important to acknowledge the dynamic nature of the
changes that occur in the autophagic system and related protein
degradative pathways during the course of glomerular disease.
.FUIPET
Mice. Mice bearing an Atg5flox allele, in which exon 3 of the Atg5 gene is
flanked by 2 loxP sequences, have been previously reported (17). PodocinCre mice were provided by L. Holzman (Renal, Electrolyte and Hypertension
Division, University of Pennsylvania School of Medicine, Philadelphia, PA,
USA) (18). Atg5-floxed mice (Atg5flox/flox) were crossed with Podocin-Cre mice
to generate podocyte-specific Atg5 knockout mice Atg5flox/flox;Podocin-Cre+
(Atg5Δpodocyte). Atg5flox/WT;Podocin-Cre+ and Atg5flox/flox;Podocin-Cre– littermates
served as controls. Atg5Δpodocyte mice were subsequently crossed to GFP-LC3
transgenic mice. Atg5 constitutive knockout mice (Atg5–/–) (16) and GFP-LC3
transgenic mice (14) have been previously reported. All mice were crossed
on a pure C57BL/6 background. The C57BL/6 strain, which is widely used
as background for transgenic and knockout mouse models, is known to
be relatively resistant to kidney injury (48), which might contribute to
the late onset of glomerulosclerosis in C57BL/6 Atg5Δpodocyte mice. Podocin-rtTA;tetO-Cre mice were provided by S. Quaggin (Samuel Lunenfeld
Research Institute, Mount Sinai Hospital, University of Toronto, Canada)
(49). To generate doxycycline-inducible podocyte-specific Atg5 knockout
mice (Atg5flox/flox;Podocin-rtTA+;tetO-Cre+) Atg5-floxed mice (Atg5flox/flox) were
crossed with Podocin-rtTA;tetO-Cre mice. TetO-Cre– littermates served as a
control. For the induction of Atg5 deletion, 12-week-old Atg5flox/flox;PodocinrtTA+;tetO-Cre+ mice received doxycycline hydrochloride (Sigma-Aldrich) via
drinking water (2 mg/ml with 5% sucrose, protected from light) for a total
of 14 days. All animal studies were approved by the Committee on Research
Animal Care, Regierungspräsidium Freiburg.
Protein overload and subsequent analysis. Atg5Δpodocyte mice (n = 5) and control
littermates (n = 6) received endotoxin-free BSA (Sigma-Aldrich; catalog
A9430) (250 mg/ml, dissolved in PBS) intraperitoneally for 5 consecutive
days with increasing dose (2, 4, 6, 8 and 10 mg/g body weight) (36, 37). Uri-
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nary albumin excretion rates were analyzed before injections and at days
1 to 7 after the first injection. To monitor the induction of autophagy,
GFP-LC3 transgenic mice received either endotoxin-free BSA (n = 4) or the
equivalent volume of PBS as control (n = 3) intraperitoneally for 7 consecutive days with increasing doses (2, 4, 6, 8, 10, 10, 10 mg/g body weight). Proteinuria was confirmed by urine dip-stix (≥20 g/l) and Coomassie gel. GFPLC3–positive autophagosomes were quantified using ImageJ software.
LPS-induced proteinuria. Atg5Δpodocyte mice and control littermates (n = 4 each)
were injected intraperitoneally with a single dose of 200 μg LPS (SigmaAldrich) (1 mg/ml in sterile PBS) in a total volume of 200 μl. Urinary albumin excretion rates were analyzed before the single dose injection and at
days 1 and 3 after the injection and normalized to urinary creatinine (38).
PAN-induced proteinuria. Atg5Δpodocyte mice and control littermates (n = 6
each) received 2 doses of intravenous PAN (Sigma-Aldrich) in 0.9% NaCl
(15 mg/ml) at day 0 and 2 (18.25 mg/100 g body weight) (33, 34). Urinary albumin excretion rates were analyzed before the 2 dose injections
and at days 1, 3, 5, 9, 13, and 16 after the first injection. Kidneys were
harvested and processed for PAS staining and electron microscopy after
the 16-day follow-up.
Adriamycin-induced proteinuria. Atg5Δpodocyte mice and control littermates
(n = 6 each) received 1 dose of intravenous Adriamycin (Sigma-Aldrich) in
0.9% NaCl (2 mg/ml) (15 μg/g body weight) (35). Urinary albumin excretion rates were analyzed before injection and 1, 2, 3, 4, and 8 weeks after
injection. Kidneys were harvested and processed for PAS staining and electron microscopy after the 8-week follow-up.
Bortezomib-induced proteinuria. Atg5Δpodocyte mice (n = 3) and control littermates (n = 4) received 1 dose of intravenous bortezomib (Janssen-Cilag) in
0.9% NaCl (1 mg/ml) (1.5 μg/g body weight) (50). Urinary albumin excretion rates were analyzed before injection and 24 hours after injection.
Urine analysis. Urinary albumin and creatinine were measured using
mouse albumin-specific ELISA (Bethyl) and creatinine kits. Proteinuria was
expressed as mg albumin/mg creatinine. In addition, Coomassie gels were
used to semi-quantitatively confirm the proteinuria (data not shown).
Histological analysis. Kidneys were fixed in 4% paraformaldehyde and
embedded in paraffin or in Lowicryl K4M resin (Electron Microscopy
Sciences) and further processed for PAS staining or electron microscopy,
respectively. Kidneys of 12-day-old Atg5Δpodocyte mice and control littermates
were fixed with 4% paraformaldehyde. Fixed kidneys were embedded in
paraffin and totally sectioned into a complete set of consecutive slices of
8 nm on a Leica microtome. The total numbers of glomeruli per kidney
were counted as previously described (51).
Immunoelectron microscopy. Kidneys of 22-month-old Atg5Δpodocyte mice and
control littermates were fixed with 4% paraformaldehyde. Fixed samples
were embedded in Lowicryl K4M resin (Electron Microscopy Sciences), and
ultrathin sections were labeled by an indirect immunogold protocol, as
described previously (52).
Immunofluorescence staining of kidney sections. Kidneys were frozen in OCT
compound and sectioned at 6 μm (Leica Kryostat). The sections were fixed
with 4% paraformaldehyde, blocked in PBS containing 5% BSA, and incubated for 1 hour with primary antibodies. After several PBS rinses, fluorophore-conjugated secondary antibodies (Invitrogen) were applied for
30 minutes. Confocal images were taken using a Zeiss laser scan microscope equipped with a ×63 water immersion objective. To determine the
number of podocytes per glomeruli, kidney sections were stained against
the podocyte nuclear marker WT1. WT1-positive cells were counted in 30
glomeruli per mouse per condition (n = 3 for each condition).
Isolation and characterization of adult mouse glomeruli. Glomeruli were isolated using Dynabead perfusion and were glass-glass homogenized in lysis
buffer (containing 20 mM CHAPS and 1% Triton X-100) (53, 54). After
centrifugation (15,000 g for 15 minutes at 4°C) protein concentration was
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determined by Dc Protein-Assay (Bio-Rad). Equal amounts of protein were
separated by SDS-PAGE.
Proteasome activity analysis. Glomeruli were lysed in T-Per (Pierce Biotechnology Inc.) with Protease Complete Inhibitor cocktail without EDTA
(Roche) (n = 3 for control and Atg5Δpodocyte mice). Protein concentration was
determined by a standard bicinchoninic acid assay (Pierce Biotechnology
Inc.) according to the manufacturer’s instructions. For the measurement of
proteasomal (chymotrypsin-like) activity, 10 μg total protein were diluted in
incubation buffer (20 mM HEPES, 0.5 mM EDTA, 5 mM DTT, 0.1 mg/ml
ovalbumin in H2O, pH 7.8) to a final volume of 50 μl. Probes were preincubated in incubation buffer for 2 hours at 4°C. Following preincubation, the
substrate Suc-LLVY-AMC (Calbiochem) was added to the probes at a final
concentration of 60 μM and to an end volume of 100 μl. Proteasomal activity
was measured in triplicate at 355 and 460 nm in a Mithras LB 940 fluorescent spectrophotometer after incubation at 37°C for 1 hour in the dark.
Oxidized protein analysis. The amount of oxidized proteins in homogenates
of glomeruli was determined by using an OxyElisa Oxidized Protein Quantitation Kit (Chemicon) according to the manufacturer’s instructions.
Patients and quantitative glomerular rt-PCR. Human renal biopsy specimens were procured in an international multicenter study, the European
Renal cDNA Bank–Kroener-Fresenius Biopsy Bank (ERCB-KFB; members
are listed in ref. 55). Biopsies were obtained from patients after informed
consent and with approval of the local ethics committees. Microdissection, RNA isolation, reverse transcription, and rt-PCR were performed as
described previously (31). Pre-developed TaqMan reagents were used for
human ATG3 (NM_022488.3) and for reference genes (Applied Biosystems). In addition, 2 biopsy samples from histologically classified membranous nephropathy and 2 controls (pretransplant living donor biopsy)
were used for immunofluorescence analysis.
Cell culture. Human and mouse podocyte cell lines were provided by
M. Saleem (Children’s Renal Unit, Bristol Royal Hospital for Children,
University of Bristol, UK) and P. Mundel (Department of Medicine, University of Miami, Miller School of Medicine, Miami, FL, USA) and were
cultured as previously described (56, 57). GFP-LC3–transgenic podocytes
were generated by retroviral transduction of pMX-GFP-rat LC3 (58) as
previously described (59, 60). For lysosomal inhibition, human podocytes
and IMCD cells were incubated with chloroquine dissolved in PBS (25 μM
final concentration) for 2, 4, and 6 hours. Western blots of cell lysates
were stained against LC3 and CD2AP as loading control. Densitometric
analysis of Western blots was performed with ImageJ software. For inhibition of the UPS, cells were incubated for 6 hours with MG132 dissolved
in DMSO (25 μM final concentration) or DMSO as control.
Antibodies. Antibodies were obtained from Acris (anti-Nephrin guinea
pig pAb, BP5030), Sigma-Aldrich (anti-podocin rabbit pAb, P0372; anti–
β-actin mouse mAb, A5441; anti-ezrin mouse mAb, E8897), Chemicon
(anti-nidogen rat mAb, MAB1946; anti-ubiquitin rabbit pAb, AB1690;
anti-ubiquitin mouse mAb, MAB1510; anti–UCH-L1 rabbit pAb, AB1761),
Abcam (anti-WT1 rabbit pAb, ab15249; anti-Lamp2 rabbit mAb, ab37024),
Biomol (anti-calnexin rabbit pAb, SPA-860), Cell Signaling Biotechnology
(anti-LC3B rabbit pAb, 2775; anti-human Atg12 rabbit pAb, 2010; antimouse Atg12 rabbit pAb, 2011), ImmunoGlobe (anti–α-actinin-4 rabbit
pAb, 0042-05), Stressgen (anti-GRP94 rat mAb, SPA-850), MBL (anti-LC3
mouse mAb, M152-3), Cosmo Bio (anti-Atg5 rabbit pAb, TMD-PH-AT5)
and Progen (anti-p62 guinea pig pAb, GP62-C). Anti-CD2AP rabbit pAb
was described previously (61).
Secondary antibodies, actin, and nuclear staining reagents were obtained
from Invitrogen (To-Pro-3, T3605; Alexa Fluor 546 phalloidin, A22283;
Alexa Fluor 488 goat anti–guinea pig IgG, A11073; Alexa Fluor 555 goat
anti-rat IgG, A21434; Alexa Fluor 488 goat anti-rat IgG; Alexa Fluor 488
donkey anti-rabbit, A21206).
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Statistics. Data were expressed as the mean ± SEM. All experiments were
performed at least 3 times. Statistical comparisons were performed with
the program Statistica using ANOVA with the Scheffe test, 2-tailed Student’s t test, 1-tailed Fisher’s exact test, or 1-tailed Mann-Whitney U test.
Differences with P < 0.05 were considered significant.
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